Published in
Rockefeller University Press, Journal of Cell Biology, 7(193), p. 1197-1212, 2011
Links
- ORCID
- ORCID
- ORCID
- Rockefeller University Press | PDF
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [www.manchester.ac.uk]
- [hdl.handle.net]
- [jcb.rupress.org] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [jcb.rupress.org] | PDF
- [air.unimi.it] | PDF
Tools
miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors
,
Daniela Galli ,
Galvez Bg,
Beatriz G. Galvez,
Tomaz Curk,
Claudia Altomare,
Flavio Ronzoni,
Jaan Toelen,
Rik Gijsbers,
Zeger Debyser,
Stefan Janssens,
Blaz Zupan,
Antonio Zaza
and other authors.
Full text: Download
Abstract
Postnatal heart stem and progenitor cells are a potential therapeutic tool for cardiomyopathies, but little is known about the mechanisms that control cardiac differentiation. Recent work has highlighted an important role for microribonucleic acids (miRNAs) as regulators of cardiac and skeletal myogenesis. In this paper, we isolated cardiac progenitors from neonatal β-sarcoglycan (Sgcb)–null mouse hearts affected by dilated cardiomyopathy. Unexpectedly, Sgcb-null cardiac progenitors spontaneously differentiated into skeletal muscle fibers both in vitro and when transplanted into regenerating muscles or infarcted hearts. Differentiation potential correlated with the absence of expression of a novel miRNA, miR669q, and with down-regulation of miR669a. Other miRNAs are known to promote myogenesis, but only miR669a and miR669q act upstream of myogenic regulatory factors to prevent myogenesis by directly targeting the MyoD 3′ untranslated region. This finding reveals an added level of complexity in the mechanism of the fate choice of mesoderm progenitors and suggests that using endogenous cardiac stem cells therapeutically will require specially tailored procedures for certain genetic diseases.